tiprankstipranks
Mereo Biopharma Group Plc (MREO)
NASDAQ:MREO
US Market

Mereo Biopharma Group Plc (MREO) Income Statement

Compare
602 Followers

Mereo Biopharma Group Plc Income Statement

Last quarter (Q4 2024), Mereo Biopharma Group Plc's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Mereo Biopharma Group Plc's net income was $-7.05M. See Mereo Biopharma Group Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 10.00M$ 1.51M$ 36.46M$ 393.00K
Gross Profit
$ 0.00$ 7.43M$ 571.00K$ 18.56M$ -15.95M
Operating Expenses
$ 47.36M$ 35.84M$ 44.51M$ 39.49M$ 21.22M
Depreciation and Amortization
$ 0.00$ 1.06M$ 1.51M$ 866.47K$ 44.00K
EBITDA
$ -47.36M$ -26.06M$ -42.06M$ -5.00M$ -37.52M
Operating Income
$ -47.36M$ -28.42M$ -43.57M$ -20.94M$ -37.57M
Other Income/Expenses
$ 4.11M$ -1.58M$ 7.48M$ 40.16M$ -129.27M
Pretax Income
$ -43.25M$ -30.00M$ -36.09M$ 14.24M$ -166.45M
Net Income
$ -43.25M$ -29.47M$ -34.20M$ 12.72M$ -163.63M
Per Share Metrics
Basic EPS
$ -0.06$ -220.04$ -350.07$ 149.93$ -3.30K
Diluted EPS
$ -0.06$ -220.04$ -350.07$ 149.93$ -3.30K
Weighted Average Shares Outstanding
739.62M 659.45M 603.20M 583.67M 338.95M
Weighted Average Shares Outstanding (Diluted)
739.62M 659.45M 603.20M 583.67M 338.95M
Currency in USD

Mereo Biopharma Group Plc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis